Common Contracts
4 similar Underwriting Agreement contracts by Human Genome Sciences Inc, Duff & Phelps Corp, Glimcher Realty Trust
Glimcher Realty Trust (Liquidation Preference of $25.00) Underwriting AgreementUnderwriting Agreement • March 27th, 2013 • Glimcher Realty Trust • Real estate investment trusts • New York
Glimcher Realty Trust, a Maryland real estate investment trust (the “Company”), which is a limited partner of Glimcher Properties Limited Partnership, a Delaware limited partnership (the “Partnership”), proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 3,600,000 shares (the “Firm Shares”) and, at the election of the Representatives, up to 400,000 additional shares to cover over-allotments (the “Optional Shares”) of 6.875% Series I Cumulative Redeemable Preferred Shares of Beneficial Interest, par value $0.01 per share (the “Preferred Stock”), of the Company (the Firm Shares and the Optional Shares that the Underwriters elect to pursuant to Section 2 hereof being collectively called the “Shares”). References throughout this Agreement to “subsidiaries” shall include the Partnership. References throughout this Agreement to “you” or “your” shall refer to Wells Fargo Securities,
Human Genome Sciences, Inc. Common Stock, par value $0.01 per share Underwriting AgreementUnderwriting Agreement • December 8th, 2009 • Human Genome Sciences Inc • In vitro & in vivo diagnostic substances • New York
Human Genome Sciences, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 15,500,000 shares (the “Firm Shares”) and, at the election of the Underwriters, up to 2,325,000 additional shares (the “Optional Shares”) of common stock, par value $0.01 per share (“Common Stock”) of the Company (the Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to Section 2 hereof being collectively called the “Shares”).
Human Genome Sciences, Inc. Common Stock, par value $0.01 per share Underwriting AgreementUnderwriting Agreement • August 3rd, 2009 • Human Genome Sciences Inc • In vitro & in vivo diagnostic substances • New York
Human Genome Sciences, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 23,215,000 shares (the “Firm Shares”) and, at the election of the Underwriters, up to 3,482,250 additional shares (the “Optional Shares”) of common stock, par value $0.01 per share (“Common Stock”) of the Company (the Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to Section 2 hereof being collectively called the “Shares”).
Underwriting AgreementUnderwriting Agreement • May 18th, 2009 • Duff & Phelps Corp • Finance services • New York
Duff & Phelps Corporation, a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 7,000,000 shares and, at the election of the Underwriters, up to 1,050,000 additional shares of Class A common stock, par value $.01 (“Stock”) of the Company. The 7,000,000 shares to be sold by the Company are herein called the “Firm Shares” and the additional shares to be sold by the Company at the election of the Underwriters are herein called the “Optional Shares”. The Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to Section 3 hereof being collectively called the “Shares”.
